Sessink PJ - Search Results

1

Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Power LA, Sessink PJ, Gesy K, Charbonneau F. Power LA, et al. Among authors: sessink pj. Hosp Pharm. 2014 Apr;49(4):355-62. doi: 10.1310/hpj4904-355. Hosp Pharm. 2014. PMID: 24958942 Free PMC article.

2

Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States.

Connor TH, Anderson RW, Sessink PJ, Broadfield L, Power LA. Connor TH, et al. Among authors: sessink pj. Am J Health Syst Pharm. 1999 Jul 15;56(14):1427-32. doi: 10.1093/ajhp/56.14.1427. Am J Health Syst Pharm. 1999. PMID: 10428450

3

Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Sessink PJ, Trahan J, Coyne JW. Sessink PJ, et al. Hosp Pharm. 2013 Mar;48(3):204-12. doi: 10.1310/hpj4803-204. Hosp Pharm. 2013. PMID: 24421463 Free PMC article.

4

Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.

Sessink PJ, Leclercq GM, Wouters DM, Halbardier L, Hammad C, Kassoul N. Sessink PJ, et al. J Oncol Pharm Pract. 2015 Apr;21(2):118-27. doi: 10.1177/1078155214522840. Epub 2014 Feb 23. J Oncol Pharm Pract. 2015. PMID: 24567041

5

Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.

Levin G, Sessink PJ. Levin G, et al. Among authors: sessink pj. J Oncol Pharm Pract. 2022 Oct;28(7):1508-1515. doi: 10.1177/10781552211030682. Epub 2021 Jul 6. J Oncol Pharm Pract. 2022. PMID: 34229499 Free PMC article.

6

Biomonitoring great, but do it the right way!

Sessink P. Sessink P. J Oncol Pharm Pract. 2019 Jan;25(1):246-247. doi: 10.1177/1078155218761800. Epub 2018 Mar 19. J Oncol Pharm Pract. 2019. PMID: 29554830 No abstract available.

7

Reduction of Contamination with Antibiotics on Surfaces and in Environmental Air in Three European Hospitals Following Implementation of a Closed-System Drug Transfer Device.

Sessink PJM, Nyulasi T, Haraldsson ELM, Rebic B. Sessink PJM, et al. Ann Work Expo Health. 2019 Apr 19;63(4):459-467. doi: 10.1093/annweh/wxz010. Ann Work Expo Health. 2019. PMID: 30852616

8

Residual chemotherapy drugs after flushing infusion lines.

Marchal MA, Robert M, Pesqué R, Jourdan N, Sessink P, Madelaine I, Levert H. Marchal MA, et al. J Oncol Pharm Pract. 2024 Mar;30(2):278-285. doi: 10.1177/10781552231175820. Epub 2023 May 30. J Oncol Pharm Pract. 2024. PMID: 37254519

9

How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?

Gilbar PJ, Chambers CR, Vandenbrouche J, Sessink PJ, Tyler TG. Gilbar PJ, et al. Among authors: sessink pj. J Oncol Pharm Pract. 2019 Jan;25(1):205-209. doi: 10.1177/1078155217753890. Epub 2018 Jan 29. J Oncol Pharm Pract. 2019. PMID: 29375015 No abstract available.

10

Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies.

Connor TH, Sessink PJ, Harrison BR, Pretty JR, Peters BG, Alfaro RM, Bilos A, Beckmann G, Bing MR, Anderson LM, Dechristoforo R. Connor TH, et al. Among authors: sessink pj. Am J Health Syst Pharm. 2005 Mar 1;62(5):475-84. doi: 10.1093/ajhp/62.5.475. Am J Health Syst Pharm. 2005. PMID: 15745910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page